Procept Capital Lease Obligations from 2010 to 2025
| PRCT Stock | USD 72.50 0.93 1.30% |
Capital Lease Obligations | First Reported 2010-12-31 | Previous Quarter 32 M | Current Value 33.6 M | Quarterly Volatility 13.2 M |
Check Procept Biorobotics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procept Biorobotics' main balance sheet or income statement drivers, such as Net Interest Income of 2.2 M, Interest Income of 6.7 M or Depreciation And Amortization of 3.6 M, as well as many indicators such as Price To Sales Ratio of 15.89, Dividend Yield of 0.0 or PTB Ratio of 6.67. Procept financial statements analysis is a perfect complement when working with Procept Biorobotics Valuation or Volatility modules.
Procept | Capital Lease Obligations |
Latest Procept Biorobotics' Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of Procept Biorobotics Corp over the last few years. Procept Biorobotics Corp capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Procept Biorobotics asset purchases. For example, Procept Biorobotics can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Procept Biorobotics control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Procept Biorobotics' Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Procept Biorobotics' overall financial position and show how it may be relating to other accounts over time.
| Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
| Timeline |
Procept Capital Lease Obligations Regression Statistics
| Arithmetic Mean | 8,097,546 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 163.16 | |
| Mean Deviation | 10,908,819 | |
| Median | 0.00 | |
| Standard Deviation | 13,211,617 | |
| Sample Variance | 174.5T | |
| Range | 33.6M | |
| R-Value | 0.81 | |
| Mean Square Error | 65.6T | |
| R-Squared | 0.65 | |
| Significance | 0.0002 | |
| Slope | 2,235,926 | |
| Total Sum of Squares | 2618.2T |
Procept Capital Lease Obligations History
About Procept Biorobotics Financial Statements
Procept Biorobotics shareholders use historical fundamental indicators, such as Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Although Procept Biorobotics investors may analyze each financial statement separately, they are all interrelated. The changes in Procept Biorobotics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Procept Biorobotics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Capital Lease Obligations | 32 M | 33.6 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.